Apnimed, Inc. <APMD.O>: BofA Global Research initiates coverage with Buy rating and price objective $41.00
APMD•Related News
Nayax Enters Into Definitive Agreement To Acquire Ips Group, A Leading Smart Parking Technology Provider
NYAX•
1606 Corp targets long-term off-takers for Lufkin powered site as it seeks AI, HPC data center users
CBDW•
Spire Global Eumetsat Awards Spire Global €4 Million One-Year Contract Renewal And Expansion
SPIR•
Anavex swings to FY26 Q3 net income of $7.82 million
AVXL•
Generation Income Properties sells six-property Dollar General portfolio, applies $2.68 million to Loci preferred redemption
GIPR•